You will find more than one new mesothelioma treatment being considered for those with the disease. The mesomark blood test was approved by the FDA in 2007. What it does is to monitor a patient's responses to treatment for bi-phasic and epithelial mesothelioma.
Mesothelioma cells release a particular protein into the blood (this is called a biomarker).
